Phase
Condition
Pancreatic Cancer
Pancreatitis
Cancer
Treatment
Proton Radiation
Surgical resection
Capecitabine
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Biopsy proven unresectable adenocarcinoma of the pancreas.
Have either unresectable, borderline resectable or medically inoperable carcinoma ofthe pancreas, or refusing surgery.
A biliary obstruction is able to participate as long as a drainage tube is in placeprior to starting treatment with Proton radiation,
Participants of child-producing potential must be willing to use contraception whileon treatment and for at least 12 months thereafter.
Required pretreatment laboratory parameters:
Absolute granulocyte count (AGC/ANC) ≥ 1.8 thou/mm3
Platelet count ≥ 100,000/mm3
Bilirubin < 2 mg/dl
ALT/SGPT < 3x upper limit of normal
Creatinine < 3 mg/dl
Exclusion
Exclusion Criteria:
Evidence of distant metastasis.
Prior surgical resection.
Previous history of invasive malignancy (except non-melanoma skin cancer and low tointermediate risk prostate cancer) unless the participant has been disease free for 5 years prior to registration.
Active or untreated infection,
Pregnant or breastfeeding women or subjects of child producing potential not willingto use medically acceptable contraception while on treatment and for at least 12months thereafter.
Previous Radiation to the abdomen.
Study Design
Study Description
Connect with a study center
University of Florida Proton Therapy Institute
Jacksonville, Florida 32206
United StatesActive - Recruiting
Northwestern Medicine Chicago Proton Center
Warrenville, Illinois 60555
United StatesActive - Recruiting
McLaren Proton Therapy Center
Flint, Michigan 48532
United StatesActive - Recruiting
Inova Schar Cancer Institute
Fairfax, Virginia 22031
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.